نتائج البحث - Alain Bitton
- يعرض 1 - 20 نتائج من 77
- اذهب إلى الاصفحة التالية
-
1
Inflammatory bowel disease and airway diseases حسب Maria Vutcovici, Paul Brassard, Alain Bitton
منشور في 2016Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study حسب Devin Abrahami, Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Christel Renoux, Alain Bitton, Laurent Azoulay
منشور في 2018Artigo -
9
-
10
L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation حسب Gilles Fortin, Katerina Yurchenko, Catherine Collette, Manuel Rubio, A-C Villani, Alain Bitton, Marika Sarfati, Denis Franchimont
منشور في 2009Artigo -
11
-
12
Patients’ perception of their involvement in shared treatment decision making: Key factors in the treatment of inflammatory bowel disease حسب Sophie Veilleux, Isabelle Noiseux, Nathalie Lachapelle, Rita Kohen, Luc Vachon, Brian White Guay, Alain Bitton, John D. Rioux
منشور في 2017Artigo -
13
Risk Factors Associated with<i>Clostridium difficile</i>Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis حسب Bhairavi Balram, Robert Battat, Alex Al Khoury, Julie Daoust, Waqqas Afif, Alain Bitton, Péter L. Lakatos, Talat Bessissow
منشور في 2018Revisão -
14
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study حسب Kelvin T. Thia, Uma Mahadevan, Brian G. Feagan, Cindy J. Wong, Alan Cockeram, Alain Bitton, Çharles N. Bernstein, William J. Sandborn
منشور في 2008Artigo -
15
-
16
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease حسب Panu Wetwittayakhlang, Farah Albader, Petra A. Golovics, Gustavo Drügg Hahn, Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Péter L. Lakatos
منشور في 2021Artigo -
17
-
18
Therapeutic Drug Monitoring Guides the Management of Crohn’s Patients with Secondary Loss of Response to Adalimumab حسب Sophie Restellini, Che‐Yung Chao, Péter L. Lakatos, Achuthan Aruljothy, Haya Aziz, Omar Kherad, Alain Bitton, Gary Wild, Waqqas Afif, Talat Bessissow
منشور في 2018Artigo -
19
-
20
Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis حسب Lara Hart, Mallory Chavannes, Omar Kherad, Chelsea Maedler, Nathalie Mourad, Victoria Marcus, Waqqas Afif, Alain Bitton, Péter L. Lakatos, Paul Brassard, Talat Bessissow
منشور في 2019Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Disease
Internal medicine
Inflammatory bowel disease
Ulcerative colitis
Biology
Crohn's disease
Gastroenterology
Environmental health
Genetics
Population
Gene
Pathology
Immunology
Inflammatory Bowel Diseases
Intensive care medicine
Genotype
Incidence (geometry)
Cohort
Optics
Physics
Sociology
Demography
Epidemiology
Single-nucleotide polymorphism
Confidence interval
Adalimumab
Inflammation
Infliximab
Alternative medicine